Kudos to Billy10us International Pharmas doing clinical

New Post Public Reply Private Reply Replies (0) Message Board
Fit007
818
Kudos to Billy10us

International Pharmas doing clinical trials in Russia. Putin won't and nor does he want to prematurely obtain early trial results on B, or any other drug for that matter, being conducted in Russia. Why? Because clinical trials being conducted there will be a cash cow for Russia for decades to come once they are established a safe and bonafide player. Economically speaking Russia is in decline and has been faltering badly for years. Revenues from crude oil has been declining dramatically from years gone by. Global pharmaceutical companies are now using them for clinical trials of their pipeline drugs. Their safety record and efficiency has been verified as being better that our own system of clinical trials in the US and that is also is true of the EU system.
And what International Pharmas are testing in Russia:
1. Merck(USA) 4 studies 500 subjects
2. Novartis(Switz.) 4 studies 77 subjects
3. Interun Therapeutics (Ireland) 3 studies 466 subjects
4.Acadia Pharm. (USA) 3 studies 158 subjects
5.Minerva Pharm.(Greece) 2 studies 380 subjects
6.Rompharm (Romania) 2 studies subjects 330
7.Sentis Pharma (India) 2 studies subjects 264
8.Janssen(J&J) 2 studies subjects 160
9.AstraZenica(UK-Swedish) 2 studies subjects 128
10.Novo Nordisc(Denmark) 2 studies subjects 118
https://across.global/wp-content/uploads/2020...2019Q1.pdf

Their costs of running trials are significantly cheaper than conducting them in the USA and the EU countries. Putin is ruthless, but he is a very smart man. He would not jeopardize the fledgling Clinical Trials industry that would become a major player on the world stage if he stepped in prematurely. He will wait with the rest of us for the proper protocols of releasing trial data. Additionally, the FDA and Europe's equivalent are on site in Russia overseeing the trials of American Pharmas. The FDA's oversight and the EU equivalent monitoring is what has given Russia the accolades and reason that worldwide Pharmas trust their Clinical Trial System. But that's just my opinion. IMO it was genius that Leo had the insight and foresight to utilize the Russian Clinical Trials system.
And to refute the argument that their vaccine (Sputnik) that Russia administered for its people is lacking efficacy or failed efficacy proves nothing. Their vaccine most likely went through a complete different trial scrutiny from the Clinical Trial system in place and Putin most likely had input on their vaccine. The drugs that US & EU Pharmas go through in Russia and the on site oversight that the FDA requires for verification of the proper protocols for phase 1,2,3 went through a much more vigorous protocols with international oversight at the venue sites where drugs were given for the different phase studies.
https://credevo.com/articles/2018/07/30/russi...y-process/

And it will be the success in Russia that will protect IPIX and B from being buried by Big Pharma and lobbyists here from reaching it’s true capabilities. BP can’t keep that enigmatic cat in the bag for much longer. IPIX will shine and prosper for all us longs and more importantly will save millions of lives from suffering and deaths to individuals and their families. For me financial remuneration will just be the icing on the cake. I welcome intelligent and thoughtful discourse.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JLL Snaps Up Prime Boston Warehouse for $36M

Updated Category News Views 88

Diving Deep into JLL's Latest Acquisition If you blinked, you might have missed JLL Income Property Trust's latest power move. These folks just laid down $36 million for a prime 54,000-square-foot Class A distribution hub in Northborough, Massachusetts. This isn't just any run-of-the-mill facility; it's 100% leased to a heavy-hitting tenant for the next 14 years with neat...

Continue Reading
SlidesAI Launches Standalone Platform for Presentations

Updated Category News Views 95

From Add-on to Standalone: SlidesAI's Big Leap You know what they say: time waits for no one, and that seems true in tech too. Those suit-and-tie presentation days? SlidesAI just took a swing at redefining them. Once a trusty sidekick locked into Google Slides, it's now captaining its own ship. Welcome to the SlidesAI standalone presentation platform—where AI meets your...

Continue Reading
Tigo Energy Faces Legal Heat Over Fraud Allegations

Updated Category News Views 51

Tigo Energy's Legal Battle Heats Up If you haven't been paying attention, it’s time to get your eyes on Tigo Energy (NASDAQ: TYGO). The company is now in the hot seat with a securities fraud lawsuit that's got investors on edge. This isn’t just a minor squabble; we're talking about allegations that could shake the ground beneath its share price. The Claims and...

Continue Reading
How Octopus AI Reinvents Financial Processes in 2026

Updated Category News Views 102

Stepping into 2026, the buzz in enterprise finance isn’t about a new gadget or slick marketing trick; it's about complex financial processes being tamed by artificial intelligence. Octopus AI is trying to spearhead this transition by automating the intricacies of financial workflows while ensuring that human judgment remains at the helm. The Austin, Texas outfit laid...

Continue Reading
Africa-Caribbean Trade Potential: A $1.65B Opportunity

Updated Category News Views 29

Untapped Opportunities Between Africa and the Caribbean Who's ready to shake up the trade game between Africa and the Caribbean? According to a fresh-off-the-press report from the International Trade Centre (ITC) and Afreximbank, we could be looking at a whopping $1.65 billion in annual trade between these two regions by 2030. That's right, a billion with a 'B'. But let...

Continue Reading
Multiconsult's Q3 2026 Results: A Gradual Rebound

Updated Category News Views 50

Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...

Continue Reading
BRIJ Medical Secures $5M: Paving Path for Product Launches

Updated Category News Views 14

In a world where medical advancements keep shifting gears, BRIJ Medical just pulled a fast one by closing a $5 million financing round—outpacing their original $3 million target. What drove this sudden increase? Well, it's simple. Their existing investors spotted an opportunity too ripe to pass up, proving yet again, money talks when confidence backs it up. Expanding...

Continue Reading
Memoir 'Pinball' Explores Life's Unpredictable Momentum

Updated Category News Views 91

Funny how some folks think life has a road map. Let me tell you, it's more like a pinball machine, barely controllable and ready to surprise you with a tilt at any moment. And that's the essence of Marshall Barber's new memoir, 'PINBALL: Remembrances of a Flaneur.' Life's Roulette: Choices and Chance Barber takes readers on a raw ride through the byways of a life...

Continue Reading
ALS Research Gains Momentum as ACT for ALS Law Signed

Updated Category News Views 58

A Major Stride in ALS Advocacy Today's not your usual day at the office for the folks championing the fight against ALS. With the President putting pen to paper, the ACT for ALS Act just turned into law, sending ripples through the community. Let me tell ya, legislation like this doesn't float by on a cloud—it's the result of grit, sleepless nights, and a dash of...

Continue Reading
OSL Unveils Instant Redemption for USDGO Plus SP

Updated Category News Views 98

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Renewi Plc's Public Disclosure in 2025

Updated Category News Views 253

Overview of the Public Disclosure Rule The public disclosure of interests in relevant securities is a structured process guided by various regulations including the Takeover Code. This specific disclosure informs stakeholders about share interests representing 1% or more in companies like Renewi Plc, enhancing market transparency and confidence. Key Disclosure Information...

Continue Reading
RaySearch Laboratories AB Seeks Institutional Share Placement

Updated Category News Views 117

RaySearch Laboratories AB Plans Share Placement Johan Löf, the CEO and Founder of RaySearch Laboratories AB, has announced an important step as he prepares to sell approximately 2 million class B shares of the company. This significant move represents about 6% of the total shares of RaySearch Laboratories AB. The shares are being offered to institutional and qualified...

Continue Reading
Key Stocks to Monitor: Micron, Cintas, and More Insights

Updated Category News Views 212

Key Stocks to Monitor Today As the trading day unfolds with U.S. stock futures displaying a mixed outlook, several stocks are poised to capture the attention of investors today. Let’s dive into the details surrounding these key players. Focus on Cintas Corp. Cintas Corp. (NASDAQ: CTAS) is on the radar as it prepares to announce its quarterly earnings. Analysts...

Continue Reading
Latest Disclosure of Interests by Rathbones Group and Insights

Updated Category News Views 79

Understanding the Latest Disclosure Activities In the labyrinth of investments and share holdings, timely disclosures play a crucial role in maintaining market transparency. Recent updates from Rathbones Group Plc regarding their interests in Warehouse REIT Plc illustrate this principle vividly. Key Disclosure Information According to Rule 8.3 of the Takeover Code,...

Continue Reading
Canada Nickel's 2024 ESG Report Highlights Sustainable Growth

Updated Category News Views 156

Canada Nickel's 2024 ESG Report Highlights Sustainable Growth Canada Nickel Company Inc. (TSXV: CNC) (OTCQB: CNIKF) has unveiled its 2024 Environmental, Social, and Governance (ESG) Report, emphasizing its commitment to sustainable practices and community engagement. This report showcases the continuous advancements in carbon storage technology, partnerships with...

Continue Reading